MicroRNA-146b: A Novel Biomarker and Therapeutic Target for Human Papillary Thyroid Cancer
Papillary thyroid cancer (PTC) is the most common tumor subtype of thyroid cancer. However, not all PTCs are responsive to current surgical and radioiodine treatment. The well-established clinical prognostic factors include tumor size, lymph node/distal metastasis, and extrathyroidal invasion. The R...
Main Authors: | Chen-Kai Chou, Rue-Tsuan Liu, Hong-Yo Kang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/18/3/636 |
Similar Items
-
The rs2910164 Genetic Variant of miR-146a-3p Is Associated with Increased Overall Mortality in Patients with Follicular Variant Papillary Thyroid Carcinoma
by: Marta Kotlarek, et al.
Published: (2018-02-01) -
Loss of DNA methylation is related to increased expression of miR-21 and miR-146b in papillary thyroid carcinoma
by: Isabella Maria Dias Payão Ortiz, et al.
Published: (2018-11-01) -
The Prognostic Value of MicroRNAs in Thyroid Cancers—A Systematic Review and Meta-Analysis
by: Cristina Alina Silaghi, et al.
Published: (2020-09-01) -
MicroRNA in Papillary Thyroid Carcinoma: A Systematic Review from 2018 to June 2020
by: Liviu Hitu, et al.
Published: (2020-10-01) -
Our experience with papillary thyroid microcancer
by: Anulekha Mary John, et al.
Published: (2014-01-01)